Hungary's foreign minister sues Viktor Orbán over $965 million ventilator purchase

Budapest – Hungary’s foreign minister and deputy prime minister, Anita Orbán, filed a criminal complaint on Thursday against the administration of Prime Minister Viktor Orbán, alleging that the purchase of 300 billion forints (about US$965 million) in ventilators during the COVID‑19 pandemic was tainted by irregularities and possible corruption. The complaint, submitted to the national prosecutor’s office, seeks a full investigation into the procurement process, the pricing of the equipment and the role of senior officials who approved the deal.

The ventilator contract, signed in early 2020 as the pandemic surged across Europe, was one of the largest emergency‑procurement actions undertaken by the Hungarian government. At the time, the country faced a sudden shortage of intensive‑care capacity and, like many of its neighbours, turned to fast‑track purchases to secure life‑saving equipment. Critics have since pointed out that the price per unit was markedly higher than comparable deals in the EU, and that the procurement bypassed the standard public‑tender procedures that normally guarantee transparency and competition. Anita Orbán’s complaint specifically accuses the former minister of health and several senior civil servants of colluding with a domestic supplier to inflate the contract value and to conceal the true cost from parliament.

Viktor Orbán’s government, which has been in power since 2010 and is known for its centralized decision‑making and nationalist rhetoric, has consistently defended the ventilator purchase as a necessary response to an unprecedented health crisis. In statements released after the complaint, the prime minister’s office said the procurement was conducted “in the best interests of the Hungarian people” and that any allegations of wrongdoing are “politically motivated attempts to undermine the government’s pandemic response.” The administration also highlighted that the ventilators were delivered and deployed in hospitals across the country, contributing to the relatively low mortality rate Hungary experienced compared to some of its regional peers.

Anita Orbán, a member of the governing Fidesz party but positioned as a reform‑oriented figure within the cabinet, has framed the complaint as a matter of legal accountability rather than partisan rivalry. In a press conference, she argued that “no one, not even the government, is above the law,” and called for an independent audit of the procurement files. Her stance reflects a growing, albeit limited, internal pressure within the ruling coalition to address concerns over corruption and the erosion of checks and balances that have been highlighted by the European Union and various civil‑society groups over the past decade.

Hungary’s political environment amplifies the significance of the complaint. The country’s political system combines a strong executive with a parliament that has been dominated by Fidesz since 2010, leading to accusations of democratic backsliding and weakened institutional oversight. The pandemic added another layer of complexity, as emergency powers granted to the government allowed for swift action but also opened avenues for potential misuse of public funds. The ventilator case sits at the intersection of these trends, illustrating how crisis‑driven procurement can become a flashpoint for broader debates about governance, transparency and the rule of law in a nation that has increasingly charted its own path within the European Union.

The outcome of the investigation could have repercussions beyond the immediate scandal. A confirmed breach of procurement rules would bolster calls from EU institutions for tighter oversight of member‑state spending, especially in sectors critical to public health and security. It could also affect Hungary’s access to EU recovery funds, which are contingent on adherence to governance standards. Moreover, the case may influence foreign investors’ perception of the Hungarian market; concerns about opaque decision‑making and potential legal risks can deter capital flows, particularly in sectors such as pharmaceuticals, medical technology and infrastructure where public contracts are pivotal. As the EU continues to scrutinize rule‑of‑law compliance among its members, the ventilator probe underscores the delicate balance Hungary must strike between sovereign policy choices and the expectations of its European partners.